This protocol is judged by an institutional overview board, an impartial team that critiques any scientific trials involving human beings. If a review will involve a Program I drug, after the board approves the protocol as ethical, the researchers need to submit an application for an investigational new drug (IND) quantity with the FDA.Some researc